Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Moodys
Johnson and Johnson
Merck
Medtronic

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for D-Proline

See Plans and Pricing

« Back to Dashboard

Drug Development Status for D-Proline: Patents, clinical trial progress, indications

D-Proline is an investigational drug.

There have been 4 clinical trials for D-Proline. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2015.

The most common disease conditions in clinical trials are Polycythemia Vera, Polycythemia, and Leukemia. The leading clinical trial sponsors are AOP Orphan Pharmaceuticals AG, PharmaEssentia Corporation (Co-Sponsor for USA), and PharmaEssentia (Co-Sponsor for USA).

There are two hundred US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for D-Proline
TitleSponsorPhase
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in RemissionAOP Orphan Pharmaceuticals AGPhase 2
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in RemissionDeutsche Krebshilfe e.V., Bonn (Germany)Phase 2
ENDURE - Efficacy and Safety of AOP2014 With CML Patients in RemissionPhilipps University Marburg Medical CenterPhase 2

See all D-Proline clinical trials

Clinical Trial Summary for D-Proline

Top disease conditions for D-Proline
Top clinical trial sponsors for D-Proline

See all D-Proline clinical trials

US Patents for D-Proline

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
D-Proline   Start Trial Novel peptidyl carbamate inhibitors of the enzyme elastase University of Kentucky Research Foundation (Lexington, KY)   Start Trial
D-Proline   Start Trial Bis(benzylpyrrolidine) derivatives as dopamine agonists Syntex (U.S.A.) Inc. (Palo Alto, CA)   Start Trial
D-Proline   Start Trial Bis(benzylpyrrolidine) derivatives useful for treating congestive heart failure and acute renal failure Syntex (U.S.A.) Inc. (Palo Alto, CA)   Start Trial
D-Proline   Start Trial Process for hair growth Toyama Chemical Co., Ltd. (Tokyo, JP)   Start Trial
D-Proline   Start Trial Arylsulfonamido-substituted hydroxamic acids Ciba-Geigy Corporation (Ardsley, NY)   Start Trial
D-Proline   Start Trial Arylsufonamido-substituted hydroxamic acids Ciba-Geigy Corporation (Tarrytown, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for D-Proline

Drugname Country Document Number Estimated Expiration Related US Patent
D-Proline Australia 4511089 2008-10-27   Start Trial
D-Proline Australia 629259 2008-10-27   Start Trial
D-Proline Canada 2001629 2008-10-27   Start Trial
D-Proline European Patent Office 0367514 2008-10-27   Start Trial
D-Proline European Patent Office 0396709 2008-10-27   Start Trial
D-Proline Japan H03503055 2008-10-27   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Boehringer Ingelheim
Dow
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.